Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure allows for selective modification, making it valuable in creating analogs for drug discovery. Commonly employed in the preparation of kinase inhibitors and receptor modulators due to the protected amine group, which facilitates controlled coupling reactions in peptide-like synthesis. Also utilized in the production of pyrrolidine-based compounds with potential antiviral or anticancer activity.